Skip to Main Content

Paper Details

Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and Outcomes.
JCO Precis Oncol
4
2017
Participants
Author NameAffiliation
Kenna R Mills ShawSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Kenna R Mills ShawSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Louise C StrongThe University of Texas MD Anderson Cancer Center
Louise C StrongThe University of Texas MD Anderson Cancer Center
Gordon B MillsSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Gordon B MillsThe University of Texas MD Anderson Cancer Center
Gordon B MillsSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Gordon B MillsThe University of Texas MD Anderson Cancer Center
Ken ChenThe University of Texas MD Anderson Cancer Center
Funda Meric-BernstamSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
  • 1 - 11

Datasets

Release 1.2